A Hero of Medicine

11.14.13 | By

In science – and especially medicine -- there are celebrated men and women whose life work has changed the world.  Doctors Salk and Sabine and their polio vaccines come quickly to mind.  Because of their work, people around the world need never fear the scourge of polio. But among the all-stars of medicine are many great scientists and researchers who, while less well known to the general public, also make a huge contribution to treating patients and preventing disease, as well as transforming our approach to innovative new treatments.

Providing Quality Care

11.13.13 | By

With nearly 1,700 care locations throughout the country and serving more than eight million Veterans, service members and military families each year, the Veterans Health Administration, part of the U.S. Department of Veterans Affairs (VA), is the largest integrated health care system in the country.

Pharmaceutical Clinical Trials in Massachusetts

11.13.13 | By

The report, "Research in Your Backyard:  Pharmaceutical Clinical Trials in Massachusetts," shows widespread clinical research underway throughout the state, including Worcester where we released the report yesterday with the

Discussing Specific Issues Facing the Alzheimer's Community

11.12.13 | By

Over the last few weeks we have devoted a fair bit of time and energy on Alzheimer’s disease. Why? It is one of the most complex diseases we face, it currently afflicts more than 5 million people in the U.S. and its current trajectory is worrisome to say the least.

Dr. William Chin Remarks at 9th Annual Personalized Medicine Conference

“PhRMA’s Outlook on Personalized Medicines”
Dr. William W. Chin, M.D.
Executive Vice President, Science & Regulatory Affairs
The Pharmaceutical Research Manufacturers of America
9th Annual Personalized Medicine Conference
Harvard University
Cambridge, MA
Wednesday, 6 November 2013

Improving Patients' Lives

11.08.13 | By

The phrase “strength in numbers” often rings true for the biopharmaceutical industry. This week we were reminded that when it comes to furthering innovation, collaboration is essential to creating a path forward and finding ways to improve patients’ lives.

Advocating for the Rare Disease Community

11.07.13 | By

Have you heard of  Batten disease? Or  of Pompe disease? Niemann-Pick Disease? These are just a few of the 7,000 rare diseases that over 30 million Americans live with every day. Another rare disease that you may not be familiar with is Mitochondrial disease. Unfortunately, Art Estopian is too familiar with the disease. Art’s son, Arturo was diagnosed with thymidine kinase 2, mitochondrial disease, an inherited condition that causes progressive muscle weakness.

Sharing Takeaways from Alzheimer's Thought Leaders

11.05.13 | By

Today, Alzheimer’s affects more than five million people in America. According to the Alzheimer’s Association, that number will triple in the next 40 years, and by 2050, caring for patients with Alzheimer’s and other forms of dementia is expected to cost the United States more than $1 trillion annually. Given the tremendous looming human and financial costs, more and more attention and resources are being devoted to finding new ways to treat those with Alzheimer’s disease and, ultimately, find a cure.

Evolution of Comparative Effectiveness Research

11.05.13 | By

Last week, I took part in an interesting multi-stakeholder roundtable convened by NEHI and the California Healthcare Institute (CHI).

Conversations Wrap Up: Pharmaceutical Supply Chain

11.05.13 | By

The U.S. pharmaceutical supply chain is the most secure in the world in part because of strong industry and government collaboration.  One benefit is that American patients can have confidence that the prescription medications they purchase from a reputable pharmacy are true to the label.


Subscribe to RSS - Opinion